Delivery Order SPE2DB24D2216-SPE2DB25FGPUA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,526.76 to AmerisourceBergen Drug Corp for 84 tablets of Xermelo 250 mg on August 25, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency on September 11, 2025, for the supply of Xermelo 250 mg tablets (84-count units) under a firm fixed-price contract with a ceiling value of $11,053.54. The order is expected to be completed by October 2, 2025, and will be fulfilled from the vendor's corporate office in Conshohocken, Pennsylvania. This is a competitive award with no set-aside designation, reflecting AmerisourceBergen's capability to compete...
- The Defense Logistics Agency awarded a delivery order valued at $5,526.76 to AmerisourceBergen Drug Corp for the supply of Xermelo 250 mg tablets (84-count units). This competitive award, issued on April 24, 2025, carries a firm fixed price structure with an ultimate completion date of May 15, 2025. The contract represents a non-set-aside procurement supporting federal medical supply needs through AmerisourceBergen's established distribution network based in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $5,526.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Xermelo 250 mg tablets (84-count units). This non-set-aside competitive award is scheduled for completion by August 11, 2025, with performance to be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Xermelo 250 mg tablets (84-count units) with a ceiling value of $5,526.76. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of October 14, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Xermelo 250 mg tablets (84-count) on September 9, 2025, with a ceiling value of $11,053.54 and an ultimate completion date of September 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $9,295.68 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the procurement of 84 boxes of Xermelo 250 mg tablets. The prime contractor will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 21, 2023 in support of the Defense Logistics Agency's logistics and procurement operations. No set aside designation or subcontractors were identified. The delivery order was awarded under an existing...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of XERMELO 250 MG TABLET 84S. The contract has a firm fixed price of $5,526.76 and a period of performance through July 23, 2025. This contract is not designated as a set-aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, which provides...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of XERMELO 250 MG TABLET 84S, a pharmaceutical product. The contract has a ceiling value of $5,526.76 and is a firm fixed-price contract. It does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and holds a significant Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $64,243.98 to supply XELJANZ XR 11 mg tablets in 30-count units. This non-competitive delivery order, issued on August 13, 2025, represents a firm fixed-price transaction with an ultimate completion date of August 14, 2025. The place of performance is listed as the company's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DB24D2216Indefinite Delivery Contract
- SPE2DB24D2216-SPE2DB25FGPUADelivery Order
The Defense Logistics Agency awarded a $11,053.54 firm fixed price delivery order to AmerisourceBergen Drug Corp for Xermelo 250 mg tablets (84-count) on September 11, 2025, with an ultimate completion date of October 2, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies critical medications and medical commodities to support military and federal healthcare systems. This delivery order for Xermelo, a prescription medication, exemplifies the company's role in fulfilling pharmaceutical requirements across the Defense Health Agency and other federal medical supply chains. The underlying IDC vehicle enables AmerisourceBergen to deliver a comprehensive range of pharmaceuticals, vaccines, and medical supplies globally to military healthcare programs, positioning the company as a key vendor in DLA's pharmaceutical procurement strategy.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 9/11/25 |